| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Encephalomyelitis, Autoimmune, Experimental | D004681 | 26 associated lipids |
| Fibrosis | D005355 | 23 associated lipids |
2E,6E-farnesol
2e,6e-farnesol is a lipid of Prenol Lipids (PR) class. 2e,6e-farnesol is associated with abnormalities such as Granulomatous Disease, Chronic, pathologic fistula and Cavitation. The involved functions are known as Regulation, Metabolic Inhibition, cholesterol biosynthetic process, Process and Transcription, Genetic. 2e,6e-farnesol often locates in Plasma membrane, Cytoplasmic matrix, cornified envelope, Epidermis and peroxisome. The associated genes with 2E,6E-farnesol are RAB3A gene, FOSL1 gene, CASP8AP2 gene, RCC1 gene and GALE gene. The related lipids are Sterols, Membrane Lipids and Steroids.
Cross Reference
Introduction
To understand associated biological information of 2E,6E-farnesol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 2E,6E-farnesol?
2E,6E-farnesol is suspected in Granulomatous Disease, Chronic, pathologic fistula and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2E,6E-farnesol
PubChem Associated disorders and diseases
What pathways are associated with 2E,6E-farnesol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 2E,6E-farnesol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 2E,6E-farnesol?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 2E,6E-farnesol
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Alves FR et al. | Biofilm biomass disruption by natural substances with potential for endodontic use. | 2013 Jan-Feb | Braz Oral Res | pmid:23306623 |
| Alves FR et al. | Antibiofilm and antibacterial activities of farnesol and xylitol as potential endodontic irrigants. | 2013 | Braz Dent J | pmid:23969910 |
| Downie MM et al. | Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. | 2004 | Br. J. Dermatol. | pmid:15491415 |
| Langman MJ et al. | Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: a comparative trial. | 1973 | Br Med J | pmid:4577839 |
| Newman CR and Montgomery DA | A double-blind trial of oral gefarnate in duodenal ulcer. | 1973 | Br J Clin Pract | pmid:4580209 |
| Coppi G et al. | [Cicatricial action of trifarnesylacetate of pantothenile (DA 1813) on normal wounds and on whounds aggravated by corticoid treatment in rats]. | 1969 | Boll. Soc. Ital. Biol. Sper. | pmid:5346779 |
| Coppi G et al. | [The antifungal properties of homofarnesoyl-hydroxamic acid (DA 2209)]. | 1969 | Boll Chim Farm | pmid:5354276 |
| Gadolini A and Facchielli G | [Gas-chromatographic behavior of gefarnate]. | 1971 | Boll Chim Farm | pmid:5147982 |
| Cerca N et al. | Confocal laser scanning microscopy analysis of S. epidermidis biofilms exposed to farnesol, vancomycin and rifampicin. | 2012 | BMC Res Notes | pmid:22591918 |
| Jeon JG et al. | Influences of naturally occurring agents in combination with fluoride on gene expression and structural organization of Streptococcus mutans in biofilms. | 2009 | BMC Microbiol. | pmid:19863808 |
| Rocha GR et al. | Effect of tt-farnesol and myricetin on in vitro biofilm formed by Streptococcus mutans and Candida albicans. | 2018 | BMC Complement Altern Med | pmid:29444673 |
| Krasowski MD et al. | The evolution of farnesoid X, vitamin D, and pregnane X receptors: insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species. | 2011 | BMC Biochem. | pmid:21291553 |
| Nasr N et al. | HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. | 2012 | Blood | pmid:22677126 |
| Song L | Recovery of E,E-farnesol from cultures of yeast erg9 mutants: extraction with polymeric beads and purification by normal-phase chromatography. | 2009 Jul-Aug | Biotechnol. Prog. | pmid:19569196 |
| Wang C et al. | Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway. | 2010 | Biotechnol. Bioeng. | pmid:20552672 |
| Ohto C et al. | Prenyl alcohol production by expression of exogenous isopentenyl diphosphate isomerase and farnesyl diphosphate synthase genes in Escherichia coli. | 2009 | Biosci. Biotechnol. Biochem. | pmid:19129660 |
| Nagai H et al. | Development of a novel PPARγ ligand screening system using pinpoint fluorescence-probed protein. | 2011 | Biosci. Biotechnol. Biochem. | pmid:21307572 |
| Nunes PM et al. | Study of trans-trans farnesol effect on hyphae formation by Yarrowia lipolytica. | 2013 | Bioprocess Biosyst Eng | pmid:23715764 |
| Rahman NK et al. | Enzymatic synthesis of farnesyl laurate in organic solvent: initial water activity, kinetics mechanism, optimization of continuous operation using packed bed reactor and mass transfer studies. | 2011 | Bioprocess Biosyst Eng | pmid:21327986 |
| Bhagatji P et al. | Multiple cellular proteins modulate the dynamics of K-ras association with the plasma membrane. | 2010 | Biophys. J. | pmid:21081081 |
| Beedle AM and Zamponi GW | Block of voltage-dependent calcium channels by aliphatic monoamines. | 2000 | Biophys. J. | pmid:10866952 |
| Kim S et al. | Evaluation of morphogenic regulatory activity of farnesoic acid and its derivatives against Candida albicans dimorphism. | 2002 | Bioorg. Med. Chem. Lett. | pmid:11958988 |
| Tsuji F et al. | The geranyl-modified tryptophan residue is crucial for ComXRO-E-2 pheromone biological activity. | 2011 | Bioorg. Med. Chem. Lett. | pmid:21636272 |
| Ling Y et al. | Synthesis and evaluation of nitric oxide-releasing derivatives of farnesylthiosalicylic acid as anti-tumor agents. | 2010 | Bioorg. Med. Chem. | pmid:20435479 |
| Ling Y et al. | Synthesis and biological evaluation of farnesylthiosalicylamides as potential anti-tumor agents. | 2014 | Bioorg. Med. Chem. | pmid:24300920 |
| Shchepin R et al. | Influence of heterocyclic and oxime-containing farnesol analogs on quorum sensing and pathogenicity in Candida albicans. | 2008 | Bioorg. Med. Chem. | pmid:18037299 |
| Endo S et al. | Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10. | 2010 | Bioorg. Med. Chem. | pmid:20304656 |
| Khalil AA et al. | Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke. | 2006 | Bioorg. Med. Chem. | pmid:16458520 |
| Abdel-Rhman SH et al. | Effect of Tyrosol and Farnesol on Virulence and Antibiotic Resistance of Clinical Isolates of Pseudomonas aeruginosa. | 2015 | Biomed Res Int | pmid:26844228 |
| Bhattacharyya S et al. | Sol-gel silica controlled release thin films for the inhibition of methicillin-resistant Staphylococcus aureus. | 2014 | Biomaterials | pmid:24099711 |
| Xie J et al. | Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro. | 2006 | Biomaterials | pmid:16490248 |
| Wright MM and McMaster CR | Phospholipid synthesis, diacylglycerol compartmentation, and apoptosis. | 2002 | Biol. Res. | pmid:12415740 |
| Inoue Y et al. | Farnesol-Induced Disruption of the Staphylococcus aureus Cytoplasmic Membrane. | 2016 | Biol. Pharm. Bull. | pmid:27150138 |
| Sato T et al. | Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade. | 2004 | Biol. Pharm. Bull. | pmid:15133261 |
| Xia J et al. | In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains. | 2017 | Biofouling | pmid:28317391 |
| Zhang X et al. | PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. | 2013 | Bioconjug. Chem. | pmid:23425093 |
| Zhang X et al. | Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel. | 2014 | Bioconjug. Chem. | pmid:25121577 |
| Bifulco M et al. | Inhibition of farnesylation blocks growth but not differentiation in FRTL-5 thyroid cells. | 1999 | Biochimie | pmid:10401660 |
| Samuel O et al. | Preparation of (1-3H) polyprenyl pyrophosphates. | 1974 | Biochimie | pmid:4375498 |
| Koyama T et al. | Substrate specificity of squalene synthetase. | 1980 | Biochim. Biophys. Acta | pmid:7357018 |
| Aharonson Z et al. | Stringent structural requirements for anti-Ras activity of S-prenyl analogues. | 1998 | Biochim. Biophys. Acta | pmid:9545527 |
| Rowat AC and Davis JH | Farnesol-DMPC phase behaviour: a (2)H-NMR study. | 2004 | Biochim. Biophys. Acta | pmid:15003880 |
| Shechter I | Biosynthesis of trans-farnesyl triphosphate in Gibberella fujikuroi. | 1973 | Biochim. Biophys. Acta | pmid:4795388 |
| Hecht SM | Mass spectrometric identification of some prenylaminopurines. | 1970 | Biochim. Biophys. Acta | pmid:5507911 |
| Shechter I | Phosphate transfer from trans-farnesyl triphosphate to AMP in Gibberella fujikuroi. | 1974 | Biochim. Biophys. Acta | pmid:4423368 |
| Bertolino A et al. | Polyisoprenoid amphiphilic compounds as inhibitors of squalene synthesis and other microsomal enzymes. | 1978 | Biochim. Biophys. Acta | pmid:210830 |
| Rowat AC et al. | Effects of farnesol on the physical properties of DMPC membranes. | 2005 | Biochim. Biophys. Acta | pmid:15963943 |
| Haug JS et al. | Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: effect of phosphatidylcholine. | 1994 | Biochim. Biophys. Acta | pmid:8061045 |
| DeBarber AE et al. | Omega-hydroxylation of farnesol by mammalian cytochromes p450. | 2004 | Biochim. Biophys. Acta | pmid:15158752 |
| Umetani N et al. | Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages. | 1996 | Biochim. Biophys. Acta | pmid:8908154 |